PinotBio, Inc.
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-10-14 | Alentis Therapeutics | PINOT-ADC linker-payload platform; claudin-1 ADC option | Not disclosed | Not disclosed | Not disclosed | Not disclosed |